Related Experiment Video

Updated: Sep 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

p53 and its co-activator p300 are inversely regulated in the mouse colon in response to carcinogen

Wataru Aizu1, Kishore Guda, Prashant Nambiar

  • 1Department of Molecular and Cell Biology, University of Connecticut, 75 North Eagleville Road, U-3125, Storrs, CT 06269, USA.

Toxicology Letters
|August 21, 2003
PubMed

Insights

Azoxymethane (AOM) carcinogen exposure caused subdued p53 gene activation in mouse colon, unlike the liver. This response may stem from reduced p300 co-activator, impacting colon cancer development.

Area of Science:

  • Molecular biology
  • Carcinogenesis research
  • Toxicology

Background:

  • The tumor suppressor protein p53 plays a critical role in cellular responses to DNA damage and carcinogenesis.
  • Azoxymethane (AOM) is a chemical carcinogen widely used to induce colon tumors in experimental models.
  • Understanding organ-specific responses to carcinogens is crucial for developing targeted cancer prevention strategies.

Purpose of the Study:

  • To investigate the p53-mediated transcriptional response in the mouse colon after acute exposure to azoxymethane (AOM).
  • To compare the p53 activation patterns in the colon versus the liver following AOM administration.
  • To elucidate the molecular mechanisms underlying differential p53 activity in various organs during chemical carcinogenesis.

Main Methods:

  • Mice were acutely exposed to the colon-specific carcinogen azoxymethane (AOM).
  • Analysis of p53-regulated gene expression in colon and liver tissues.
  • Assessment of p53 stabilization and the expression of its co-activator, p300.

Main Results:

  • No significant induction of p53-regulated genes was observed in the mouse colon following AOM exposure.
  • A small population of apoptotic colonocytes exhibited increased Bax staining, indicating limited p53 activity.
  • In contrast, the liver displayed robust increases in p53-regulated gene expression after AOM treatment.
  • Reduced p53 gene activation in the colon correlated with a decrease in the expression of the transcriptional co-activator p300.
  • p53 stabilization was not found to be the cause of the subdued response in the colon.

Conclusions:

  • Inefficient gene activation by p53 in the colon may contribute to the organ-specific carcinogenic effects of AOM.
  • The reduced expression of p300 in the colon could impair p53-mediated tumor suppression.
  • These findings highlight differential p53 pathway functionality across organs in response to chemical carcinogens.

More Related Videos

In vitro Organoid Culture of Primary Mouse Colon Tumors07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...